Humans Mitomycin Gemcitabine Hematuria *Non-Muscle Invasive Bladder Neoplasms Deoxycytidine/therapeutic use Administration Intravesical *Urinary Bladder Neoplasms/drug therapy *Cystitis Chemical cystitis Cistitis química Cáncer de vejiga sin invasión muscular Gemcitabina intravesical Intravesical gemcitabine Intravesical mitomycin Mitomicina intravesical Non-muscle invasive bladder cancer Recurrence rates Tasas de recurrencia

Male Humans *Papillomavirus Infections/complications/epidemiology/prevention & control Human Papillomavirus Viruses Mendelian Randomization Analysis Papillomaviridae/genetics Human papillomavirus 18 *Urinary Bladder Neoplasms/epidemiology/complications HPV prevalence bladder cancer human papillomavirus mendelian randomization meta-analysis

Humans Mitomycin/therapeutic use Antibiotics Antineoplastic BCG Vaccine/therapeutic use *Non-Muscle Invasive Bladder Neoplasms Neoplasm Recurrence Local/drug therapy *Urinary Bladder Neoplasms/pathology Administration Intravesical Neoplasm Invasiveness Bladder cancer Device-assisted Emda Intravesical drug administration Nmibc

Humans Female *Carcinoma Transitional Cell/chemically induced/epidemiology/genetics DNA Adducts/adverse effects *Drugs Chinese Herbal/adverse effects Taiwan/epidemiology *Urinary Bladder Neoplasms Carcinogens *Kidney Neoplasms/chemically induced/epidemiology/genetics *Aristolochic Acids/adverse effects/analysis *Ureteral Neoplasms/chemically induced/epidemiology *Urinary Tract Aristolochia DNA adduct Mass spectrometry Nephropathy Renal pelvic cancer Ureteral cancer

Humans Cost-Benefit Analysis *Early Detection of Cancer *Urinary Bladder Neoplasms/diagnosis/epidemiology

Humans *Obturator Nerve/physiology/surgery Network Meta-Analysis Transurethral Resection of Bladder *Urinary Bladder Neoplasms/surgery/pathology Reflex bladder cancer lumbar anesthesia obturator nerve block transurethral resection of bladder tumor conflicts of interest to declare.

Humans *Urinary Bladder/pathology Cystectomy/methods Prognosis Prospective Studies Neoplasm Recurrence Local/pathology *Urinary Bladder Neoplasms/pathology Biomarkers biomarker neutrophil-to-lymphocyte ratio prognostic factor radical cystectomy recurrence urothelial carcinoma

*Carcinoma Transitional Cell/drug therapy Humans Organoids Precision Medicine *Urinary Bladder Neoplasms/drug therapy Urothelium/pathology Metastases Personalized medicine Stem cells Transurethral resection

microbiota systematic review urinary bladder neoplasms

Humans *Carcinoma Transitional Cell *Urinary Bladder Neoplasms/pathology Retrospective Studies BCG Vaccine/therapeutic use Administration Intravesical Adjuvants Immunologic *Organ Transplantation Neoplasm Invasiveness Neoplasm Recurrence Local/pathology Bcg Bladder cancer Chemotherapy Mitomycin Transplanted patients

Cohort Studies *Dietary Fats/adverse effects Female Humans Male Prospective Studies Risk Factors Sugars *Urinary Bladder Neoplasms/epidemiology/etiology bladder cancer diet epidemiology fat oil risk factor

Cohort Studies Female Humans Male Prospective Studies Risk Factors Tea *Urinary Bladder Neoplasms/epidemiology/etiology Dose–response analysis Epidemiology Smoking Urinary bladder cancer

*Cell Cycle Proteins/genetics Humans Prospective Studies Sensitivity and Specificity *Urinary Bladder Neoplasms/diagnosis/pathology Adxbladder Biomarker Bladder cancer Diagnostic accuracy Mcm5 Systematic review

Blood Transfusion/*mortality Combined Modality Therapy Cystectomy/*mortality Humans *Perioperative Care Prognosis Survival Rate Urinary Bladder Neoplasms/pathology/*therapy Bladder cancer Blood transfusion Cystectomy Meta-analysis Oncology Systematic review

Biomarkers/urine Carcinogenesis Carcinogens/toxicity Female Humans Male *Tobacco Products/adverse effects *Urinary Bladder Neoplasms/etiology Biomarkers of exposure Bladder cancer Carcinogens Heated tobacco product Urine disclosures.

Asian People/genetics Genetic Predisposition to Disease Humans *Methylenetetrahydrofolate Reductase (NADPH2)/genetics Polymorphism Single Nucleotide *Urinary Bladder Neoplasms/genetics Folate Mthfr Polymorphism Urinary Neoplasms bladder cancer

Humans *Urinary Bladder Neoplasms/surgery/pathology Lasers Urethra/surgery Treatment Outcome Length of Stay 2-micron laser bladder cancer meta-analysis randomized controlled trials trans-urethral resection of bladder tumor

Data Systems Humans Magnetic Resonance Imaging/methods *Multiparametric Magnetic Resonance Imaging Reproducibility of Results Urinary Bladder/diagnostic imaging/pathology *Urinary Bladder Neoplasms/diagnostic imaging/surgery Bladder cancer Bladder cancer staging Multiparametric magnetic resonance imaging Muscle-invasive bladder cancer conflict of interest to disclose.

Aged Antineoplastic Combined Chemotherapy Protocols/*therapeutic use Carcinoma Transitional Cell/*drug therapy/*pathology Female Humans Immune Checkpoint Inhibitors/*therapeutic use Liver Neoplasms/secondary Male Middle Aged Survival Analysis Urinary Bladder Neoplasms/*drug therapy/*pathology bladder cancer immune checkpoint inhibitors immunotherapy meta-analysis urothelial carcinoma

Case-Control Studies Female Humans Male *Menarche Odds Ratio Risk Factors *Urinary Bladder Neoplasms/epidemiology/etiology Bladder cancer Menarche Meta-analysis